Cellogel Electrophoresis Co. originates from the industrial research activities of Dr G.B. Del Campo who established the company Chemetron, specialised in chromatography and electrophoresis, immediately after graduating in 1958. In the same year Dr Del Campo set up the company Chemetron Chimica which specialised in the production of kits for clinical chemistry analysis of blood, urine, etc. The two companies operated for 13 years (1958-1971), without Italian or european competitors, in the field of clinical chemistry.
Chemetron’s most important success of was the invention of Cellogel, patented internationally by Dr Del Campo in 1963 and distributed in 36 countries worldwide. Cellogel was, in fact, the product favoured both by researchers and by users who utilised it for routine analyses. The success of Cellogel was totally due to the numerous applications proposed by Dr Del Campo’s research staff.

The magazine Chimica Clinica Acta published works on Cellogel by authors who worked in the most famous European, North American, Japanese, Australian and Argentinian research institutes. Even the sacred texts of internal Medicine such as Introzzi in Italy, Gras in Spain and Margni in Argentina quoted Cellogel in the chapters on electrophoresis and immunofixation. The official pharmacopoeia, both Italian (FU) and French, English and American (USP) mention the analytical methods of Cellogel for the control of proteins such as human albumin, pure immunoglobulins, etc.
The best known international journals, Clinical Chemistry, Biochimica Clinica, etc. published works by researchers who used Cellogel for their immunological techniques, for the separation of isoenzymes or the determination of single proteins. Cellogel was distributed by such important companies as: Whatman Ltd (U.K.), Serva Heidelberg (Germany), Fisher Scientific (USA), etc. Important customers who have utilised Cellogel and published the results of their research have been, among others, the Carolinska Institute (Sweden), the Weizmann Institute (Israel), the chain of Max Planck Institut (Germany), MIT – Massachusetts Istitute of Technology, Boston (USA).
In the mid-sixties new companies were established and started with the distribution of Cellogel, including Sebia (France), Atom and Biosystems (Spain), Labometer (Portugal), International Cientifica (Mexico) and other firms in South America (Venezuela, Brazil and Argentina).
In 1988 Dr Del Campo transferred the brands and patents to other companies among which Malta Chemetron which has produced Cellogel in recent years and then to the Cellogel Electrophoresis Company of Milan.
The new company has a programme covering the whole field of clinical electrophoresis which includes research and automation, aiming, above all, at quality and innovation with new products, in particular equipment for manual electrophoresis for small and large numbers of tests/hour, automatic equipment for high resolution electrophoresis and densitometer-scanner for rapid quantitative readings of electrophoretic migrations.